Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C genotype 4
TY Abdel Ghaffar, S El Naghi… - Journal of viral …, 2019 - Wiley Online Library
Direct‐acting antivirals have become available for treating chronic HCV (hepatitis C virus)
infection in adults and, recently, in children at least 12 years old. Our aim was to investigate …
infection in adults and, recently, in children at least 12 years old. Our aim was to investigate …
Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
NI Musa, IE Mohamed, AS Abohalima - Egyptian Liver Journal, 2020 - Springer
Background The impact of direct-acting antivirals (DAAs) remains a debate, whether they
accelerate the recurrence rate of hepatitis C virus (HCV)-related hepatocellular carcinoma …
accelerate the recurrence rate of hepatitis C virus (HCV)-related hepatocellular carcinoma …
[HTML][HTML] New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
A Essawy, M Mehrez, SM Shaheen, H El Garem… - …, 2024 - f1000research.com
Background: Several studies have resulted in controversial data about the recurrence or
new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were …
new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were …
Hepatitis C genotype 4: A report on resistance‐associated substitutions in NS3, NS5A, and NS5B genes
N Fadl, TZ Salem - Reviews in Medical Virology, 2020 - Wiley Online Library
Author Contribution FN performed the literature review and wrote the manuscript; STZ
coauthored, edited, and reviewed the manuscript. Abstract Treatment response in Hepatitis …
coauthored, edited, and reviewed the manuscript. Abstract Treatment response in Hepatitis …
[PDF][PDF] peer review: 1 approved with reservations, 1 not approved
A Essawy, M Mehrez, SM Shaheen, H El Garem… - 2022 - researchgate.net
Background: Several studies have resulted in controversial data about the recurrence or
new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were …
new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were …
[PDF][PDF] peer review: awaiting peer review
A Essawy, M Mehrez, SM Shaheen, H El Garem… - 2021 - academia.edu
Background: Several studies have resulted in controversial data about the recurrence or
new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were …
new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were …
[引用][C] direct‐acting anti‐viral (DAA) therapy needs strong safety and efficacy check
RS Mahla - Alimentary Pharmacology & Therapeutics, 2018 - Wiley Online Library
Letter: directâ•’acting antiâ•’viral (DAA) therapy needs strong safety and efficacy check
Page 1 5. Surmiak M, Sanak M. Different forms of alpha-1-antitrypsin and neutrophil …
Page 1 5. Surmiak M, Sanak M. Different forms of alpha-1-antitrypsin and neutrophil …